Hep Email Update High-Dose Hepatitis B Vaccine More Effective for People With HIV People who received a higher dose had stronger and longer-lasting immune responses. Advertisement FDA Reconsiders Accelerated Approvals of Immunotherapy Drugs An advisory panel reviewed follow-up data on checkpoint inhibitors, voting to maintain four approvals and rescind two. Statin Use Linked to Reduced Risk for Liver Cancer Recurrence Use of cholesterol-lowering medications was also associated with reduced mortality from liver cancer and other causes. NIH HEAL Initiative Meets the Moment National Institutes of Health’s Helping to End Addiction Long-term Initiative is finding scientific solutions to address the opioid crisis. #Coronavirus Get the latest updates! The Hep Magazine Archives To read past issues of Hep, click the link! Advertisement Science News High-Dose Hepatitis B Vaccine More Effective for People With HIV Statin Use Linked to Reduced Risk for Liver Cancer Recurrence FDA Reconsiders Accelerated Approvals of Immunotherapy Drugs Red Meat Consumption Linked to Higher NAFLD Risk Newsfeed International Overdose Awareness Day 2021 [VIDEO] NIH HEAL Initiative Meets the Moment A New Road Map to Help Countries End Hepatitis B and C by 2030 FDA Grants Full Approval of Pfizer-BioNTech COVID-19 Vaccine Science News High-Dose Hepatitis B Vaccine More Effective for People With HIV Statin Use Linked to Reduced Risk for Liver Cancer Recurrence FDA Reconsiders Accelerated Approvals of Immunotherapy Drugs Red Meat Consumption Linked to Higher NAFLD Risk Newsfeed International Overdose Awareness Day 2021 [VIDEO] NIH HEAL Initiative Meets the Moment A New Road Map to Help Countries End Hepatitis B and C by 2030 FDA Grants Full Approval of Pfizer-BioNTech COVID-19 Vaccine

You are receiving this email because you opted in at one of our websites. At your request, this message was sent to newsletter@newslettercollector.com by update@hepmag.com. Please remember to add update@hepmag.com to your email address book, so that these updates aren't blocked as spam.

To change your subscription information and preferences, please visit your personal preferences page. Or you can unsubscribe completely from this list.

To forward this message, please do not use the forward button of your email application, because this message was made specifically for you only. Instead use the forward page in our newsletter system.

Did you receive this email from a friend? You can subscribe and you will receive our next newsletter directly to your inbox.

Our mailing address is: